Valaciclovir Bluefish 500 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

valaciclovir bluefish 500 mg film-coated tablets

bluefish pharmaceuticals ab - valaciclovir - film-coated tablet - 500 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; valaciclovir

Valaciclovir Teva 500 mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

valaciclovir teva 500 mg film-coated tablets

teva pharma b.v. - valaciclovir - film-coated tablet - 500 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; valaciclovir

Valaciclovir 500 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

valaciclovir 500 mg film-coated tablets

accord healthcare ireland ltd. - valaciclovir - film-coated tablet - 500 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; valaciclovir

VALACICLOVIR ACTAVIS valaciclovir hydrochloride 1000mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

valaciclovir actavis valaciclovir hydrochloride 1000mg tablet bottle

medis pharma pty ltd - valaciclovir hydrochloride monohydrate, quantity: 1223.4 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; titanium dioxide; hypromellose; hyprolose; macrogol 400 - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of opthalmic zoster. for the treatment of recurrent herpes labialis (cold sores). for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with vaciclor, it is recommended that patients use safer sex practices (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

VALACICLOVIR ACTAVIS valaciclovir hydrochloride 1000mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

valaciclovir actavis valaciclovir hydrochloride 1000mg tablet blister pack

medis pharma pty ltd - valaciclovir hydrochloride monohydrate, quantity: 1223.4 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; titanium dioxide; hypromellose; hyprolose; macrogol 400 - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of opthalmic zoster. for the treatment of recurrent herpes labialis (cold sores). for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with vaciclor, it is recommended that patients use safer sex practices (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

VALACICLOVIR ACTAVIS valaciclovir hydrochloride 250mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

valaciclovir actavis valaciclovir hydrochloride 250mg tablet blister pack

medis pharma pty ltd - valaciclovir hydrochloride monohydrate, quantity: 305.85 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; titanium dioxide; hypromellose; hyprolose; macrogol 400 - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of opthalmic zoster. for the treatment of recurrent herpes labialis (cold sores). for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with vaciclor, it is recommended that patients use safer sex practices (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Valaciclovir New Zealand - English - Medsafe (Medicines Safety Authority)

valaciclovir

glaxosmithkline nz limited - valaciclovir hydrochloride 1112mg equivalent to valaciclovir 1000 mg;   - film coated tablet - 1000 mg - active: valaciclovir hydrochloride 1112mg equivalent to valaciclovir 1000 mg  

Valaciclovir New Zealand - English - Medsafe (Medicines Safety Authority)

valaciclovir

glaxosmithkline nz limited - valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg;   - film coated tablet - 500 mg - active: valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg  

Valaciclovir AB 250 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

valaciclovir ab 250 mg film-coat. tabl.

aurobindo sa-nv - valaciclovir hydrochloride 305,85 mg - eq. valaciclovir 250 mg - film-coated tablet - 250 mg - valaciclovir hydrochloride 305.85 mg - valaciclovir